Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Class A common stock, $0.001 par value
-
Shares outstanding
-
162,474,849
-
Total 13F shares
-
263,669
-
Share change
-
+191,920
-
Total reported value
-
$2,696,000
-
Price per share
-
$10.22
-
Number of holders
-
10
-
Value change
-
+$1,997,209
-
Number of buys
-
7
-
Number of sells
-
1
Institutional Holders of IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value (CYTH) as of Q2 2021
As of 30 Jun 2021,
IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value (CYTH) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
263,669 shares.
The largest 10 holders included
VANGUARD GROUP INC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, BlackRock Inc., MORGAN STANLEY, ROYAL BANK OF CANADA, Tower Research Capital LLC (TRC), Advisory Services Network, LLC, and CAPTRUST FINANCIAL ADVISORS.
This page lists
10
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.